V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250012156 | 250008188 | 1.81 | 71.3 | null | 2014-09-06 | 2016-05-10 | ANAGRELIDE | N | N | 250009071 | DOCETAXEL |
| 250012157 | 250008190 | 1.78 | 101 | Disease modification (D) | 2015-03-25 | 2015-04-16 | COMMAND trial | 2 | N | 250010007 | NOT MATCHED |
| 250012158 | 250008190 | null | 63.4 | Curative (C) | 2015-06-16 | 2019-02-19 | CISPLATIN + GEMCITABINE | 2 | N | 250010007 | AZACITIDINE |
| 250012159 | 250008193 | null | null | Palliative (P) | 2016-03-26 | 2016-04-01 | Temozolomide 200mg/m2 | N | N | 250010404 | CHOP R |
| 250012160 | 250011060 | 1.56 | null | Palliative (P) | 2018-12-27 | 2018-12-27 | CYTARABINE | N | N | 250010821 | NIVOLUMAB |
| 250012161 | 250008197 | 1.78 | 75 | Curative (C) | 2019-07-16 | 2019-07-17 | IPM | N | N | 250010823 | PEMETREXED |
| 250012162 | 250008199 | 1.68 | 74 | Curative (C) | 2018-12-24 | 2018-12-29 | INTERFERON | N | N | 250011409 | DASATINIB |
| 250012163 | 250012191 | 0 | 71 | Palliative (P) | 2019-03-20 | 2019-03-27 | COMMAND trial | 2 | N | 250011913 | AZACITIDINE |
| 250012164 | 250008203 | 1.56 | 85.6 | Palliative (P) | 2014-05-24 | 2014-05-24 | BUSULFAN | N | N | 250012125 | OXALIPLATIN + MDG |
| 250012165 | 250008206 | 1.55 | 85 | Palliative (P) | 2018-01-08 | 2018-09-09 | PACLITAXEL | 02 | N | 250012125 | BORTEZOMIB |
| 250012166 | 250008208 | 1.72 | 85 | Palliative (P) | 2018-01-23 | 2018-07-27 | GemCarbo Days 1+8 | 2 | N | 250013214 | CARBOPLATIN |
| 250012167 | 250008210 | 1.67 | 89 | Palliative (P) | 2017-03-17 | 2017-03-31 | Docetaxel | N | N | 250013495 | COMMAND TRIAL |
| 250012168 | 250008213 | 1.68 | 54.8 | Neo-adjuvant (N) | 2016-06-25 | 2016-11-02 | Eribulin | 02 | N | 250013836 | IPM |
| 250012169 | 250008214 | null | 63.4 | Palliative (P) | 2019-03-30 | 2019-04-06 | Carboplatin + Paclitaxel (weekly) | N | N | 250013988 | GEMCARBO |
| 250012170 | 250008216 | 1.56 | 75 | Curative (C) | 2019-03-22 | 2019-03-29 | CARBOPLATIN | 02 | N | 250014072 | IPM |
| 250012171 | 250008218 | 1.77 | 42 | Palliative (P) | 2015-05-25 | 2015-07-28 | CHOP R - 21 days | 02 | N | 250014335 | IPM |
| 250012172 | 250008222 | 1.64 | 74 | Palliative (P) | 2017-07-14 | 2017-07-14 | Carboplatin + Paclitaxel (3 weekly) | null | N | 250016148 | GEMCARBO |
| 250012173 | 250008223 | 1.64 | 61.9 | Palliative (P) | 2015-11-06 | 2015-11-06 | Rituximab | N | N | 250016315 | IPM |
| 250012174 | 250008226 | 1.79 | 71 | Neo-adjuvant (N) | 2015-11-28 | 2015-11-28 | GemCarbo Days 1+8 | N | N | 250016619 | GEMCARBO |
| 250012175 | 250008228 | 0 | 78 | Curative (C) | 2015-12-28 | 2015-12-28 | CISPLATIN + GEMCITABINE | 2 | N | 250017056 | BUSULPHAN |
| 250012176 | 250008230 | 1.8 | 0 | Not known (9) | 2015-10-15 | 2015-10-15 | GEMCARBO | 02 | N | 250017200 | IPM |
| 250012177 | 250008233 | 1.7 | 0 | Palliative (P) | 2017-12-28 | 2017-12-28 | Bevacizumab + CISPLATIN + PEMETREXED | N | N | 250017259 | CARBOPLATIN + VINORELBINE |
| 250012178 | 250008235 | null | 85 | Disease modification (D) | 2016-07-03 | 2016-07-03 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 250017324 | IPM |
| 250012179 | 250008237 | 1.71 | 87.9 | Palliative (P) | 2016-07-18 | 2016-07-26 | Bevacizumab + CISPLATIN + PEMETREXED | 2 | null | 250017799 | GEMCARBO |
| 250012180 | 250012812 | 1.78 | 84.8 | Curative (C) | 2018-07-18 | 2018-07-18 | GEMCITABINE | 02 | N | 250018033 | DOCETAXEL |
| 250012181 | 250008240 | 0 | 94.7 | Disease modification (D) | 2017-06-02 | 2017-06-03 | IMATINIB | N | N | 250018262 | IBRUTINIB |
| 250012182 | 250008244 | 0 | 64.5 | Disease modification (D) | 2017-06-15 | 2017-06-19 | IPM | N | N | 250018361 | GEMCITABINE |
| 250012183 | 250008245 | 1.74 | 143 | Disease modification (D) | 2016-06-12 | 2016-07-18 | GemCarbo Days 1+8 | 2 | null | 250018706 | CARBOPLATIN + VINORELBINE |
| 250012184 | 250008247 | 1.69 | 65.8 | Palliative (P) | 2018-11-16 | 2018-12-14 | GemCarbo Days 1+8 | N | Y | 250018735 | AZACITIDINE |
| 250012185 | 250008248 | 1.67 | 81.7 | Palliative (P) | 2019-06-08 | 2019-06-08 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 250019028 | GEMCITABINE |
| 250012186 | 250008249 | null | 81 | Neo-adjuvant (N) | 2015-01-01 | 2015-06-11 | CARBOPLATIN | N | N | 250019032 | CARBOPLATIN + PACLITAXEL |
| 250012187 | 250008250 | null | 81.2 | Disease modification (D) | 2017-03-10 | 2017-03-10 | Carboplatin AUC 6 - 10 | null | N | 250019175 | GEMCITABINE |
| 250012188 | 250008253 | null | 70.5 | null | 2018-05-21 | 2018-08-25 | IMATINIB | N | null | 250019583 | TRASTUZUMAB |
| 250012189 | 250008255 | null | 71 | Palliative (P) | 2016-07-22 | 2016-12-18 | AML LI-1 Trial | Y | N | 250019777 | CARBOPLATIN + ETOPOSIDE |
| 250012190 | 250008256 | 1.74 | null | Palliative (P) | 2019-05-12 | 2019-06-07 | GemCarbo Days 1+8 | 2 | N | 250019822 | PEMETREXED |
| 250012191 | 250008258 | null | null | Adjuvant (A) | 2014-09-20 | 2014-10-05 | GEMCARBO | N | N | 250020140 | FLAG + IDARUBICIN |
| 250012192 | 250008260 | 1.5 | 50.5 | Palliative (P) | 2015-07-05 | 2015-07-10 | GEMCARBO | 02 | Y | 250020418 | NOT MATCHED |
| 250012193 | 250011095 | 1.63 | 83 | Palliative (P) | 2018-09-04 | 2018-11-13 | Pemetrexed | 2 | N | 250020985 | PACLITAXEL |
| 250012194 | 250008272 | null | 45.5 | Palliative (P) | 2014-02-23 | 2015-01-08 | ANAGRELIDE | N | N | 250023193 | FBC |
| 250012195 | 250008274 | 1.76 | 76 | Disease modification (D) | 2018-10-18 | 2018-11-30 | COMMAND trial | 02 | N | 250025984 | COMMAND TRIAL |
| 250012196 | 250008278 | 1.78 | 81.7 | Curative (C) | 2016-02-02 | 2016-02-02 | GEMCARBO | 2 | N | 250027278 | COMMAND TRIAL |
| 250012197 | 250008279 | null | 78.4 | Curative (C) | 2019-04-16 | 2019-04-23 | ESHAP R | 99 | N | 250027713 | IRINOTECAN + MDG |
| 250012198 | 250008280 | 1.6 | 61.2 | Curative (C) | 2014-05-23 | 2014-09-20 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 250028026 | GEMCITABINE |
| 250012199 | 250008282 | null | 80.8 | Palliative (P) | 2016-07-11 | 2016-07-18 | Rituximab (Maintenance) | 02 | N | 250028595 | GEMCARBO |
| 250012200 | 250008284 | null | 74 | Palliative (P) | 2015-09-05 | 2015-09-08 | CARBOPLATIN + GEMCITABINE | null | N | 250029279 | CARBOPLATIN + PACLITAXEL |
| 250012201 | 250008286 | 1.59 | 85.4 | Disease modification (D) | 2017-02-16 | 2017-02-16 | ANAGRELIDE | N | N | 250029468 | FEC + DOCETAXEL |
| 250012202 | 250008294 | null | 67.85 | Palliative (P) | 2016-11-20 | 2017-03-12 | null | 02 | null | 250000545 | PEMBROLIZUMAB |
| 250012203 | 250008295 | null | 69.7 | Palliative (P) | null | 2016-07-18 | Paclitaxel 7 day | N | N | 250001228 | PEMETREXED |
| 250012204 | 250008297 | 1.51 | 80 | Palliative (P) | null | 2019-05-23 | Eribulin | 2 | N | 250004070 | CISPLATIN + GEMCITABINE |
| 250012205 | 250008299 | 1.78 | 62.4 | Palliative (P) | 2016-06-17 | 2016-10-06 | IPM | N | N | 250005783 | CARBOPLATIN + VINORELBINE |